Recent studies identified somatic mutations of JAK3 in a minority of acute megakaryoblastic leukemia patients [7-10], in a high-risk childhood acute lymphoblastic leukemia case [11], and in cutaneous T-cell lymphoma patients [12]. This evidence concerns the gene JAK3 and primary cutaneous T-cell non-Hodgkin lymphoma.